Data to be presented at the ASGCT Annual Meeting include an oral presentation from Sangamo’s flagship neurology epigenetic regulation program Nav1.7 to treat chronic neuropathic pain.

Inconsistencies in data presentation could harm efforts against COVID-19 New research shows broad array of different content, formats in data available on national public health institutes ...

Data featured in oral presentation and poster session at 48th European Cystic Fibrosis Conference WALTHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a ...

Perspective Therapeutics Announces Acceptance of Key Radiopharmaceutical Data for Presentation at ASCO 2025 Annual Meeting April 23, 2025 — 12:30 pm EDT Written by None for Quiver Quantitative -> ...

Oral presentation of RAMP 201 trial results including updated subgroup analyses in recurrent low-grade serous ovarian cancer Oral presentation of investigator-sponsored study of avutometinib plus ...

Jade Biosciences, Inc. announced that new preclinical data on its investigational anti-APRIL monoclonal antibody, JADE101, will be presented at the 62nd European Renal Association Congress in ...